Pfizer
Timothy Keller has an extensive work experience spanning several decades. Timothy held various roles at different companies, with the majority of their career spent at Alcatel-Lucent and Pfizer. Notably, they served as the SVP & General Counsel at Alcatel-Lucent, leading a team of 250 legal and compliance professionals. At Pfizer, they held the positions of Senior Tax Counsel and Vice President, Corporate Insurance and Global Recovery Program. Prior to these roles, they worked as an associate at law firms Tucker, Flyer, Sanger & Lewis and Rogers & Wells.
Timothy Keller attended Georgetown University Law Center from 1983 to 1986, earning a JD (Juris Doctorate) degree in Law. Prior to that, they studied at the University of Vermont from 1979 to 1983, earning a BA (Bachelor of Arts) degree in Economics.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.